Akanda (AKAN) Competitors $1.30 -0.03 (-2.26%) Closing price 03:59 PM EasternExtended Trading$1.35 +0.05 (+3.54%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock AKAN vs. TCRT, OMGA, AIM, INAB, SBFM, GNPX, IMCC, KZIA, HCWB, and CELZShould you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Alaunos Therapeutics (TCRT), Omega Therapeutics (OMGA), AIM ImmunoTech (AIM), IN8bio (INAB), Sunshine Biopharma (SBFM), Genprex (GNPX), IM Cannabis (IMCC), Novogen (KZIA), HCW Biologics (HCWB), and Creative Medical Technology (CELZ). These companies are all part of the "pharmaceutical products" industry. Akanda vs. Its Competitors Alaunos Therapeutics Omega Therapeutics AIM ImmunoTech IN8bio Sunshine Biopharma Genprex IM Cannabis Novogen HCW Biologics Creative Medical Technology Akanda (NASDAQ:AKAN) and Alaunos Therapeutics (NASDAQ:TCRT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk. Is AKAN or TCRT more profitable? Akanda's return on equity of 0.00% beat Alaunos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AkandaN/A N/A N/A Alaunos Therapeutics N/A -169.34%-124.28% Do institutionals and insiders believe in AKAN or TCRT? 1.0% of Akanda shares are owned by institutional investors. Comparatively, 27.7% of Alaunos Therapeutics shares are owned by institutional investors. 20.4% of Akanda shares are owned by company insiders. Comparatively, 16.1% of Alaunos Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, AKAN or TCRT? Akanda has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Alaunos Therapeutics has a beta of -0.8, meaning that its share price is 180% less volatile than the S&P 500. Which has stronger valuation & earnings, AKAN or TCRT? Akanda has higher revenue and earnings than Alaunos Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkanda$840K2.21-$4.10MN/AN/AAlaunos Therapeutics$10K829.84-$4.68MN/AN/A Does the media refer more to AKAN or TCRT? In the previous week, Alaunos Therapeutics had 1 more articles in the media than Akanda. MarketBeat recorded 4 mentions for Alaunos Therapeutics and 3 mentions for Akanda. Alaunos Therapeutics' average media sentiment score of 0.66 beat Akanda's score of -0.52 indicating that Alaunos Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Akanda 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Negative Alaunos Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAkanda beats Alaunos Therapeutics on 6 of the 10 factors compared between the two stocks. Get Akanda News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AKAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKAN vs. The Competition Export to ExcelMetricAkandaMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.86M$10.24B$5.49B$8.93BDividend YieldN/A2.11%5.38%4.12%P/E RatioN/A16.6826.2019.89Price / Sales2.2127.28415.50166.23Price / CashN/A22.8736.4957.06Price / Book0.433.648.055.39Net Income-$4.10M$233.36M$3.15B$248.50M7 Day Performance-8.84%1.46%1.92%2.96%1 Month Performance10.17%3.31%4.90%6.02%1 Year Performance-70.85%-11.73%35.95%20.44% Akanda Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKANAkanda0.5252 of 5 stars$1.30-2.3%N/A-70.6%$1.86M$840K0.00110News CoverageTCRTAlaunos Therapeutics0.7597 of 5 stars$4.31-3.9%N/A-28.0%$6.99M$10K0.0040Gap UpOMGAOmega Therapeutics2.5663 of 5 stars$0.13-21.8%$8.50+6,700.0%-94.4%$6.92M$8.10M-0.09120Gap UpAIMAIM ImmunoTech1.5976 of 5 stars$9.05-4.7%$275.00+2,938.7%-75.6%$6.91M$146K-19.2620INABIN8bio2.9277 of 5 stars$2.24+0.2%$180.00+7,953.7%-91.5%$6.75MN/A-0.1620SBFMSunshine Biopharma3.1881 of 5 stars$1.45+1.4%$15.00+934.5%+259.9%$6.62M$34.87M-0.013News CoverageGNPXGenprex1.8701 of 5 stars$0.24+2.6%N/A-85.9%$6.51MN/A0.0020Gap UpIMCCIM Cannabis0.7455 of 5 stars$2.90+2.5%N/A+1.3%$6.47M$39.44M-4.53340News CoverageGap UpKZIANovogen3.3994 of 5 stars$6.28-7.2%$57.50+815.6%-38.8%$6.46M$1.51M0.0012HCWBHCW Biologics3.3279 of 5 stars$4.44-4.9%$35.00+688.3%-85.6%$6.42M$2.57M-0.1940News CoverageGap DownCELZCreative Medical Technology0.9624 of 5 stars$2.45flatN/A-29.1%$6.35M$10K-0.645Negative News Related Companies and Tools Related Companies TCRT Competitors OMGA Competitors AIM Competitors INAB Competitors SBFM Competitors GNPX Competitors IMCC Competitors KZIA Competitors HCWB Competitors CELZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AKAN) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKAN Stock Alerts